SCHEMBL6167568

SCHEMBL6167568

COc1cc(-c2cc(CNC(=O)C3CCNCC3)ccn2)cc(OC)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPC1 O15118 2/20 0.45
PKM P14618 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 2/20 0.45
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
EPHX2 P34913 1/20 0.42
HPGD P15428 1/20 0.42
KCNH2 Q12809 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
POLB P06746 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ROCK2 O75116 1/20 0.40
KDM1A O60341 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168415 0.91 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2NPC1PKMRAB9A
SCHEMBL13800060 0.78 TP53 (0.48) KMT2AACHEBACE1
SCHEMBL4117314 0.74 KCNH2 (0.39) ALDH1A1NPC1KCNH2
Fumaric Acid SCHEMBL4118677 0.74 ACHE (0.45) NPC1RAB9AKMT2AACHEBACE1
Maleic Acid SCHEMBL4118674 0.74 ACHE (0.45) NPC1RAB9AKMT2AACHEBACE1
SCHEMBL6207985 0.73 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KMT2AHPGDKCNH2
SCHEMBL4115040 0.73 RECQL (0.47) NPC1RAB9APOLBKDM1AHDAC1
SCHEMBL4032240 0.72 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2NPC1PKMRAB9A
SCHEMBL4114136 0.72 NPC1 (0.53) ALDH1A1SMN1; SMN2NPC1RAB9AACHE
SCHEMBL4114573 0.71 DYRK1A (0.39) SMN1; SMN2KMT2AKDM1AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494670-A1 MEDICINE FOR TREATING CANCER Kowa Co., Ltd. (JP) 2005-01-12 EP disclosed
WO-2003086397-A1 MEDICINE FOR TREATING CANCER KOWA CO., LTD. (JP) 2003-10-23 WO disclosed